Skip to main content
SpringerLink
Log in
Book cover

Posterior Fossa Tumors in Children pp 657–665Cite as

Atypical Teratoid/Rhabdoid Tumors: Current Chemotherapy and Future Directions

  • Chapter

  • 2142 Accesses

Abstract

Atypical teratoid/rhabdoid tumors (AT/RT) are relatively uncommon malignancies that can arise anywhere in the body, most frequently in the kidneys and the central nervous system (CNS). The central nervous system atypical teratoid/rhabdoid tumor (CNS AT/RT) is a highly malignant neoplasm that commonly affects infants and young children and has an extremely poor prognosis.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   269.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   349.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   349.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Beckwith JB, Palmer NF (1978) Histopathology and prognosis of Wilms’ tumor: results from the first National Wilms’ Tumor Study. Cancer 41:1937–1948

    Article  CAS  PubMed  Google Scholar 

  2. Packer RJ, Biegel JA, Blaney S et al (2002) Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop. J Pediatr Hematol Oncol 24:337–342

    Article  PubMed  Google Scholar 

  3. Tekautz TM, Fuller CE, Blaney S et al (2005) Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. J Clin Oncol 23:1491–1499

    Article  CAS  PubMed  Google Scholar 

  4. Von Hoff K, Hinkes B, Dannenmann-Stern E et al (2011) Frequency, risk factors and survival of children with atypical teratoid rhabdoid tumors (AT/RT) of the CNS diagnosed between 1988 and 2004, and registered to the German HIT database. Pediatr Blood Cancer 57:978–985

    Article  Google Scholar 

  5. Lefkowity IB, Rorke LB, Packer RJ et al (1987) Atypical teratoid tumor of infancy: definition of an entity. Ann Neurol 22:448–449

    Google Scholar 

  6. Rorke LB, Packer RJ, Biegel JA (1996) Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg 85:56–65

    Article  CAS  PubMed  Google Scholar 

  7. Kleihues P, Cavanee WK (2000) Pathology and genetics of tumours of the nervous system, 3rd edn. IARC Press, Lyon

    Google Scholar 

  8. Biegel JA, Zhou JY, Rorke LB et al (1999) Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 59:74–79

    CAS  PubMed  Google Scholar 

  9. Bourdeaut F, Lequin D, Brugieres L, Reynaud S, Dufour C, Doz F et al (2011) Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumor. Clin Cancer Res 17:31–38

    Article  CAS  PubMed  Google Scholar 

  10. Eaton KW, Tooke LS, Wainwright LM, Judkins AR, Biegel JA (2011) Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr Blood Cancer 56:7–15

    Article  PubMed Central  PubMed  Google Scholar 

  11. Burger PC, Yu IT, Tihan T et al (1998) Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma. Am J Surg Pathol 22:1083–1092

    Article  CAS  PubMed  Google Scholar 

  12. Lafay-Cousin LC, Hawkins AS, Carret D et al (2012) Central nervous system atypical teratoid rhabdoid tumours: the Canadian Paediatric Brain Tumour Consortium experience. Eur J Cancer 48:353–359

    Article  CAS  PubMed  Google Scholar 

  13. Ginn KF, Gajjar A (2012) Atypical teratoid rhabdoid tumor: current therapy and future directions. Front Oncol 2:114

    Article  PubMed Central  PubMed  Google Scholar 

  14. Chi SN, Zimmerman MA, Yao X et al (2009) Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. J Clin Oncol 27:385–389

    Article  PubMed Central  PubMed  Google Scholar 

  15. Zimmerman MA, Goumnerova LC, Proctor M et al (2005) Continuous remission of newly diagnosed and relapsed central nervous system atypical teratoid/rhabdoid tumor. J Neurooncol 72:77–84

    Article  PubMed  Google Scholar 

  16. Athale UH, Duckworth J, Odame I et al (2009) Childhood atypical teratoid rhabdoid tumor of the central nervous system: a meta-analysis of observational studies. J Pediatr Hematol Oncol 31:651–663

    Article  PubMed  Google Scholar 

  17. Perilongo G, Sutton L, Czaykowski D et al (1991) Rhabdoid tumor of the central nervous system. Med Pediatr Oncol 19:310–317

    Article  CAS  PubMed  Google Scholar 

  18. Weinblatt M, Kochen J (1992) Rhabdoid tumor of the central nervous system. Med Pediatr Oncol 20:258

    Article  CAS  PubMed  Google Scholar 

  19. OlsonT A, Bayar E, Kosnik E et al (1995) Successful treatment of disseminated central nervous system malignant rhabdoid tumor. J Pediatr Hematol Oncol 17:71–75

    Article  Google Scholar 

  20. Geyer JR, Sposto R, Jennings M et al (2005) Multi agent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children’s Cancer Group. J Clin Oncol 23:7621–7631

    Article  PubMed  Google Scholar 

  21. Campen CJ, Dearlove J, Pertap S et al (2012) Concurrent cyclophosphamide and craniospinal radiotherapy for pediatric high-risk embryonal brain tumors. J Neurooncol 110:287–291

    Article  CAS  PubMed  Google Scholar 

  22. Slavc I, Chocholous M, Leiss U et al (2014) Atypical teratoid rhabdoid tumor: improved long-term survival with an intensive multimodal therapy and delayed radiotherapy. The Medical University of Vienna Experience. Cancer Med 3(1):91–100

    Article  PubMed Central  PubMed  Google Scholar 

  23. Shih CS, Hale GA, Gronewold L, Tong X, Laningham FH, Gilger EA, Srivastava DK, Kun LE, Gajjar A, Fouladi M (2008) High- dose chemotherapy with autologous stem cell rescue for children with recurrent malignant brain tumors. Cancer 112(6):1345–1353

    Article  CAS  PubMed  Google Scholar 

  24. Gardner SL, Asgharzadeh S, Green A (2008) Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors. Pediatr Blood Cancer 51(2):235–240

    Article  PubMed  Google Scholar 

  25. Fidani P, De Loris MA, Serra A et al (2009) A multimodal strategy based on surgery, radiotherapy, ICE regimen and high dose chemotherapy in atypical teratoid/rhabdoid tumours: a single institution experience. J Neurooncol 92:177–183

    Article  PubMed  Google Scholar 

  26. Finkelstein-Shechter T, Gassas A, Mabbott D et al (2010) Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapy. J Pediatr Hematol Oncol 32:182–186

    Article  Google Scholar 

  27. Nicolaides T, Tihan T, Horn B et al (2010) High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system. J Neurooncol 98:117–123

    Article  PubMed Central  PubMed  Google Scholar 

  28. Park ES, Sung KW, Baek HJ et al (2012) Tandem high-dose chemotherapy and autologous stem cell transplantation in young children with atypical teratoid/rhabdoid tumor of the central nervous system. J Korean Med Sci 27:135–140

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Prevarskaya N, Skryma R, Shuba Y (2010) Ion channels and the hallmarks of cancer. Trends Mol Med 16:107–121

    Article  CAS  PubMed  Google Scholar 

  30. Davies AR, Melsy MJ, Kozlowski RZ (2004) Volume sensitive organic osmolyte anion channels in cancer. Ann N Y Acad Sci 1028:38–55

    Article  CAS  PubMed  Google Scholar 

  31. Sontheimer H (2008) An unexpected role for ion channels in brain tumor metastasis. Exp Biol Med 233:779–791

    Article  CAS  Google Scholar 

  32. Banderali U, Roy G (1992) Anion channels for amino acids in MDCK cells. Am J Physiol 263:C1200–C1207

    CAS  PubMed  Google Scholar 

  33. Kirk K, Strange K (1998) Functional properties and physiological roles of organic solute channels. Annu Rev Physiol 60:719–739

    Article  CAS  PubMed  Google Scholar 

  34. Banderali U, Jayanthan A, Hoeksema KA et al (2012) Ion channels in pediatric CNS Atypical Teratoid/Rhabdoid Tumor (AT/RT) cells: potential targets for novel therapeutic agents. J Neurooncol 107:111–119

    Article  CAS  PubMed  Google Scholar 

  35. Morozov A, Lee SJ, Zhang ZK et al (2007) NI1 inducesinterferon signaling and spindle checkpoint in rhabdoid tumors. Clin Cancer Res 13:4721–4730

    Article  CAS  PubMed  Google Scholar 

  36. Venneti S, Le P, Martinez D et al (2011) p16INK4A and p14ARF tumor sup- pressor pathways are deregulated in malignant rhabdoid tumors. J Neuropathol Exp Neurol 70:596–609

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  37. Rosato RR, Almenara JA, Grant S (2003) The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF11. Cancer Res 63:3637–3645

    CAS  PubMed  Google Scholar 

  38. Alao JP, Stavropoulo AV, Lam EW et al (2006) Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells. Mol Cancer 5:8

    Article  PubMed Central  PubMed  Google Scholar 

  39. Knipstein JA, Birks DK, Donson AM et al (2012) Histone deacetylase inhibition decreases proliferation and potentiates the effect of ionizing radiation in atypical teratoid/rhabdoid tumor cells. Neurooncology 14:175–183

    CAS  Google Scholar 

  40. Kosaka C, Sasaguri T, Komiyama Y et al (2001) All-trans retinoic acid inhibits vascular smooth muscle cell proliferation targeting multiple genes for cyclins and cyclin dependent kinases. Hypertens Res 24:579–588

    Article  CAS  PubMed  Google Scholar 

  41. Li Y, Shen Q, Kim HT et al (2011) The rexinoid bexarotene represses cyclin D1 transcription by inducing the DEC2 transcriptional repressor. Breast Cancer Res Treat 128:667–677

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  42. Lee S, Cimica V, Ramachandra N et al (2011) Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival. Cancer Res 71:3225–3235

    Article  CAS  PubMed  Google Scholar 

  43. Maris JM, Morton CL, Gorlick R et al (2010) Initial testing of the aurora kinase A inhibitor MLN 8237 by the Pediatric Preclinical Testing Program (PPTP). Pediatr Blood Cancer 55:26–34

    PubMed Central  PubMed  Google Scholar 

  44. Dar AA, Goff LW, Majid S et al (2010) Aurora kinase inhibitors rising stars in cancer therapeutics. Mol Cancer Ther 9:268–278

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  45. Ogino S, Kubo S, Abdul-Karim FW et al (2001) Comparative immunohistochemical study of insulin-like growth factor II and insulin-like growth factor receptor type 1 in pediatric brain tumors. Pediatr Dev Pathol 4:23–31

    Article  CAS  PubMed  Google Scholar 

  46. D’Cunja J, Shalaby T, Rivera P et al (2007) Antisense treatment of IGF- IR induces apoptosis and enhances chemosensitivity in central nervous system atypical teratoid/rhabdoid tumour cells. Eur J Cancer 43:1581–1589

    Article  PubMed  Google Scholar 

  47. Arcaro A, Doepfner KT, Boller D et al (2007) Novel role for insulin as an autocrine growth factor for malignant brain tumour cells. Biochem J 406:57–66

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  48. Ozkan EE (2011) Plasma and tissue insulin-like growth factor-I receptor(IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: a review. Mol Cell Endocrinol 344:1–24

    Article  CAS  PubMed  Google Scholar 

  49. Rowe DL, Ozbay T, Bender LM et al (2008) Nor dihydroguaiaretic acid, a cytotoxic insulin-like growth factor-I receptor/HER2 inhibitor in trastuzumab-resistant breast cancer. Mol Cancer Ther 7:1900–1908

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  50. Adam PJ, Ostermann E, Lamche HR et al (2011) Pharmacodynamic proper- ties and antitumor efficacy of BI 836845, a fully human IGFligand neutralizing antibody. Mol Cancer Ther 10(Suppl 11):abstr. A208

    Article  Google Scholar 

  51. Koos B, Jeibmann A, Lunenburger H et al (2010) The tyrosine kinase c- Abl promotes proliferation and is expressed in atypical teratoid and malignant rhabdoid tumors. Cancer 116:5075–5081

    Article  CAS  PubMed  Google Scholar 

  52. Jayanthan A, Bernoux D, Bose P et al (2011) Multi-tyrosine kinase inhibitors in preclinical studies for pediatric CNSAT/RT: evidence for synergy with Topoisomerase-I inhibition. Cancer Cell Int 11:44

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  53. Jeibmann A, Buerger H, Fruhwald M et al (2006) No evidence for epidermal growth factor receptor amplification and overexpression in a typical teratoid/rhabdoid tumors. Acta Neuropathol 112:513–514

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pediatric Oncology, Department of Pediatrics, Acıbadem University, School of Medicine, Istanbul, Turkey

    Cengiz Canpolat M.D.

Authors
  1. Cengiz Canpolat M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cengiz Canpolat M.D. .

Editor information

Editors and Affiliations

  1. Neurosurgery, Acıbadem University, Istanbul, Istanbul, Turkey

    M. Memet Özek

  2. Pediatric Neurosurgery, Santobono Children's Hospital, Naples, Napoli, Italy

    Giuseppe Cinalli

  3. Dept. Neurosurgery, Royal Childrens Hospital, Melbourne, Victoria, Australia

    Wirginia Maixner

  4. Pediatric Neurosurgery, Hopital Necker-Enfants Malades, Paris, Paris, France

    Christian Sainte-Rose

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Canpolat, C. (2015). Atypical Teratoid/Rhabdoid Tumors: Current Chemotherapy and Future Directions. In: Özek, M., Cinalli, G., Maixner, W., Sainte-Rose, C. (eds) Posterior Fossa Tumors in Children. Springer, Cham. https://doi.org/10.1007/978-3-319-11274-9_42

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-11274-9_42

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-11273-2

  • Online ISBN: 978-3-319-11274-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation